Table 1_Post-thyroidectomy ultrasonography versus thyroglobulin as a surveillance tool for locoregional recurrence in patients with differentiated thyroid carcinoma: A single centre 10-year study.docx

BackgroundDifferentiated thyroid cancer (DTC; including papillary and follicular thyroid cancers) has favourable survival outcomes, with related mortality below 10%. However, 20–30% of patients experience recurrence. Surveillance primarily relies on neck ultrasonography (US) and serum thyroglobulin (Tg) assessment.
PurposeThis study evaluated the diagnostic performance of neck US in detecting locoregional recurrence following total thyroidectomy and compared its effectiveness with serum Tg.
Materials and methodsThis retrospective, single-centre study analysed 941 DTC patients who underwent total thyroidectomy and neck US between 2009 and 2019. Suspicious US findings were correlated with serum Tg levels and anti-thyroglobulin antibody status. Disease persistence (<6 months)/recurrence (>6 months) was confirmed via fine-needle aspiration cytology/biopsy, iodine scintigraphy, CT, or PET-CT. Patients without US-detected lesions were assessed clinically, biochemically, and via follow-up US.
ResultsNeck US had a sensitivity of 98.9%, specificity of 63.1%, positive predictive value (PPV) of 50.7%, negative predictive value (NPV) of 99.3%, and an accuracy of 73.01%. Serum Tg (cutoff 1.8 ng/ml derived from receiver operating characteristic analysis) had a sensitivity of 69.2%, specificity of 91.8%, PPV of 61.4%, NPV of 94.1%, and an accuracy of 88.28%. Among 149 patients with US-detected lesions and Tg <1.8 ng/ml, 22 (14.8%) had locoregional recurrence. Five of 43 patients with Tg <0.1 ng/ml had confirmed recurrence. Among lymph nodes ≤6 mm in short-axis diameter with an indistinct fatty hilum, 69.6% were benign. Persistence was detected in 38.5% of patients within six months post-treatment, whereas most true recurrences (61.5%) manifested after six months.
ConclusionNeck US is highly sensitive but moderately specific for detecting locoregional recurrence post-thyroidectomy, complementing Tg. Study limitations include its retrospective design, single-centre setting, and lack of inter-observer variability assessment. A risk-adapted multimodal surveillance strategy with 6-monthly US for two years is recommended.